High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
Davatchi
F
F
Behçet's Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Tehran, Iran.
Shahram
F
F
Chams
H
H
Jamshidi
A R
AR
Nadji
A
A
Chams
C
C
Akbarian
M
M
Gharibdoost
F
F
D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use*; D031300:Retinal Vasculitis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014792:Visual Acuity / Q000187:drug effects* / Q000502:physiology
D007166:Immunosuppressive Agents; D008727:Methotrexate